Munir Hassan Taher, Fcca, Cfa
Director
Emirates Biotech
Emirates
United Arab Emirates
Biography
Munir Taher has over 15 years of combined professional experience in asset management, private equity and corporate finance. In 2007, he joined Global to assist in managing USD1bn of proprietary investments spread across various asset classes through out the region. In 2009, he became part of a special task force to set up a USD1.5bn fund to facilitate Global’s first round of debt restructuring and subsequently played a key role in raising ~USD200mn in realization proceeds during the first year of the restructuring to service debt obligations. He later played a similar role in the successful conclusion of Global’s USD1.7bn second and final round of restructuring in 2013 and co-led transformation of principle investments division into a new asset management business pillar with an AUM of USD500mn. The Special Situations Asset Management applies a value driven divestment strategy through proactive roles in portfolio companies facilitating USD270mn in realization proceeds at exit multiples exceeding 1.6x to agreed target values. Munir has represented on the board of several companies such as Al Razzi Holding (Kuwait), Emirates Retakaful (UAE), Saudi Yemeni Healthcare (Yemen), Bindar Trading (Jordan), CNBC Pakistan, CNBC Africa (South Africa), Murdoch University (UAE) and JS Global Capital (Pakistan) He began his career in Kenya working for several large institutions in the corporate finance department. He obtained his Fellowship from the Association of Chartered Accountants from UK in 2001 and became CFA charter holder in 2015
Research Interest
Molecular Biology and Molecular Genetics